Skip to main navigation Skip to search Skip to main content

Recurrent or refractory primary central nervous lymphoma: therapeutic considerations

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalExpert Review Anticancer Therapy
Volume13
StatePublished - Sep 2013

Disciplines

  • Medicine and Health Sciences

Cite this